This longitudinal study followed 340 clients over a decade, comparing sleeve gastrectomy against medical management for type 2 diabetes.
New England Journal of Medicine · 2024 Bariatric Surgery
56% T2D remission at 10 years
Long-Term Outcomes of Sleeve Gastrectomy vs. Medical Management in Type 2 Diabetes
What this means for clients
- Surgical clients held glycemic improvement a decade out.
- Cardiovascular risk fell against the non-surgical group.
- Remission is not guaranteed and depends on lifestyle change.
The study
Rubino F, Cohen RV, Mingrone G, et al.. Long-Term Outcomes of Sleeve Gastrectomy vs. Medical Management in Type 2 Diabetes. New England Journal of Medicine. 2024. 10-year follow-up. 340 clients
DOI: 10.1056/NEJMoa2024001
View the source study ↗Published research is summarised here for general information. It is not a description of, or a promise about, any individual treatment.